Skandinaviska Enskilda Banken (SEB)’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-45,280
| Closed | -$776K | – | 1076 |
|
|
2021
Q3 | $776K | Sell |
45,280
-62,320
| -58% | -$1.07M | ﹤0.01% | 824 |
|
|
2021
Q2 | $2.31M | Hold |
107,600
| – | – | 0.01% | 626 |
|
|
2021
Q1 | $1.62M | Hold |
107,600
| – | – | 0.01% | 720 |
|
|
2020
Q4 | $1.41M | Sell |
107,600
-20,900
| -16% | -$275K | 0.01% | 745 |
|
|
2020
Q3 | $1.24M | Sell |
128,500
-29,100
| -18% | -$281K | 0.01% | 686 |
|
|
2020
Q2 | $1.8M | Buy |
157,600
+8,200
| +5% | +$93.8K | 0.01% | 591 |
|
|
2020
Q1 | $1.55M | Buy |
+149,400
| New | +$1.55M | 0.02% | 539 |
|
|
2016
Q2 | – | Sell |
-120,600
| Closed | -$1.01M | – | 728 |
|
|
2016
Q1 | $1.01M | Sell |
120,600
-301,700
| -71% | -$2.52M | 0.01% | 585 |
|
|
2015
Q4 | $4.08M | Buy |
+422,300
| New | +$4.08M | 0.05% | 246 |
|